P1158 EFFICACY AND SAFETY OF BOCEPREVIR-BASED THERAPY IN HCVG1 TREATMENT-EXPERIENCED PATIENTS WITH ADVANCED FIBROSIS/CIRRHOSIS: THE ITALIAN AND SPANISH NPP EARLY ACCESS PROGRAM

✍ Scribed by Bruno, S.; Bollani, S.; Pascasio, J.M.; Zignego, A.L.; Di Marco, V.; Magni, C.; Rizzetto, M.; Ciancio, A.; Alberti, A.; Piovesan, S.; Mangia, A.; De la Revilla, J.; Larrubia, J.R.; Gea, F.; Babudieri, S.; Perez-Alvarez, R.; Colletta, C.; Barcena, R.; Forns, X.; Romero-Gomez, M.; Koch, M.; Massari, M.; Caremani, M.; Crespo, J.; Navarro, J.M.; Arenas, J.; Delgado, M.B.; Pirisi, M.; Zuin, M.; Licata, A.; Mazzotta, F.; Colombo, A.; Russello, M.; Fermandez, I.; Santantonio, T.; Fernandez-Rodriguez, C.M.; Farina, F.; Ruiz Antoran, B.; Maisonneuve, P.; Craxì, A.; Calleja, J.L.

• Book ID: 122133714
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 58 KB
• Volume: 60
• Category: Article
• ISSN: 0168-8278
• DOI: 10.1016/S0168-8278(14)61318-0